What is 10x Genomics, Inc.'s unrealized gains on investments?

10x Genomics, Inc. (TXG) reported unrealized gains on investments of $0 in Q1 2026.

What is the long-term trend for 10x Genomics, Inc.'s unrealized gains on investments?

Over 3 years (2022 to 2025), 10x Genomics, Inc.'s unrealized gains on investments has grown at a 44.2% compound annual growth rate (CAGR), from $4K to $12K.

10x Genomics, Inc. TXG Unrealized Gains on Investments

Unrealized Gains on Investments at other companies

Twist Bioscience CorporationTWST

——

Other financials

Income statement

See full

Revenue$150.8M-2.6%

Gross profit$106.2M+0.7%

Operating income-$17.0M+56.7%

Net income-$13.5M+60.8%

EPS (diluted)-$0.10+64.3%

Balance sheet

See full

Cash & equivalents$490.3M+30.0%

Total debt$81.4M+1.6%

Total equity$814.3M+15.2%

Total assets$1.0B+12.4%

Cash flow

See full

Operating cash flow$26.1M-24.0%

CapEx$1.6M-15.6%

Free cash flow$24.5M-24.4%

Valuation

See full

Market cap$4.41B+154%

Enterprise value$4B+199%

P/S6.9×+4.1×

Profitability

See full

Gross margin69.6%+1.2pp

Operating margin-6.1%-2.7pp

Net margin-3.5%-1.6pp

FCF margin19.1%—

Returns & leverage

See full

Return on equity-3%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s unrealized gains on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 10x Genomics, Inc.'s unrealized gains on investments?: 10x Genomics, Inc. (TXG) reported unrealized gains on investments of $0 in Q1 2026.
What is the long-term trend for 10x Genomics, Inc.'s unrealized gains on investments?: Over 3 years (2022 to 2025), 10x Genomics, Inc.'s unrealized gains on investments has grown at a 44.2% compound annual growth rate (CAGR), from $4K to $12K.